In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
--Cardinal Health today reported fourth quarter fiscal year 2024 revenues of $59.9 billion, an increase of 12% from the prior year. GAAP operating earnings were $1.2 billion and GAAP diluted EPS was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results